Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
Sanofi buys into Teva's anti-TL1A therapy for IBD | pharmaphorum
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva enters billion-dollar settlement in US opioid case — MedWatch
Mylan's Chairman was Right | Ctech
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva in Talks to Buy Allergan's Generic-Drug Unit - WSJ
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva Pharmaceutical Set for Major Layoffs in Israel, U.S.: Report
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Jury finds Teva fueled opioid addiction in New York - YouTube
Teva divesting $1 billion in assets to clear Allergan deal
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug
Teva drops migraine-drug patent case against Eli Lilly | Nasdaq
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva Pharmaceutical Industries – The Forward
Biden Admin Urges Supreme Court to Hear 'Skinny Labels' Case Between Teva, GSK
Teva profit plummets, stock slides | Ctech
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
